Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Stimulus, Brexit talks weigh on Asian markets

Published 10/12/2020, 10:40 am
Updated 10/12/2020, 10:42 am
© Reuters.
XAU/USD
-
US500
-
DJI
-
HK50
-
PFE
-
AUS200
-
DX
-
GC
-
LCO
-
CL
-
JP225
-
HK50
-
IXIC
-
META
-

By Pete Schroeder

Dec 10 (Reuters) - Asian markets looked set to slide Thursday as investors tracked negotiations with significant economic implications in the U.S. and Europe.

Australian S&P/ASX 200 futures YAPcm1 were down 0.28% in early trading, while {{178|Japan's NiNikkei 225 futures NKc1 were down 0.06%.

Hong Kong's Hang Seng index futures .HSI .HSIc1 were down 1.15%.

On Wall Street, markets took a bit of a hit as investors awaited further news on economic stimulus and COVID-19 vaccines. And ongoing negotiations between the British and European Union over the terms of Britain's exit added another dash of uncertainty for investors.

The Dow Jones Industrial Average .DJI fell 0.49%. The S&P 500 .SPX lost 0.90% after hitting a record high earlier in the day, while the Nasdaq Composite .IXIC dropped 1.99%.

In the U.S. Congress continued talks on additional economic stimulus, with House lawmakers voting to pass a one-week stopgap funding bill to give more time for talks. British Prime Minister Boris Johnson warned the European Union on Wednesday it must scrap demands that he says are unacceptable if there is to be a Brexit trade deal to avoid a turbulent breakup in three weeks. levels of event risk surrounding the EU-UK trade talks ... and ongoing negotiations on a fresh U.S. stimulus package in Washington continued to dampen market volatility," wrote analysts at ANZ Bank in a research memo.

Facebook FB.O dragged down other big tech stocks on the news that the U.S. Federal Trade Commission and nearly every U.S. state had sued the social media company, saying it engaged in anticompetitive practices and should potentially be broken up. recent run of optimism on the back of positive vaccine news took a hit after officials in Britain, the first Western nation to adopt a wide vaccination effort, cautioned that people with a history of significant allergic reactions responded adversely to the Pfizer (NYSE:PFE) PFE.N vaccine. U.S. dollar rose for the fourth straight session Wednesday, with the dollar up 0.16% against a basket of currencies =USD to 91.065. Longer-term U.S. Treasury yields rose on stimulus and vaccine hopes. futures were largely flat LCOc1 CLc1 , while spot gold prices XAU= were down more than 2%, with the start of vaccine treatment reducing demand for the safe-haven investment. Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.